Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
Q9BVT8 | Transmembrane and ubiquitin-like domain-containing protein 1 | ||
Q9BWV1 | Brother of CDO | ||
Q9BX73 | TM2 domain-containing protein 2 | ||
Q9BXS4 | Transmembrane protein 59 | ||
Q9BXX0 | EMILIN-2 | ||
Q9BYC5 | Alpha-(1,6)-fucosyltransferase | ||
Q9BYJ0 | Fibroblast growth factor-binding protein 2 | ||
Q9BZA7 | Protocadherin-11 X-linked | ||
Q9BZM4 | UL16-binding protein 3 | ||
Q9BZR6 | Reticulon-4 receptor |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
31404475 | The Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose‐Type Lectin | Diniz A | 2019 Nov 04 |
|
31144994 | Pharmacokinetics and Clinical Pharmacology Considerations of GalNAc3-Conjugated Antisense Oligonucleotides | Wang Y | 2019 May 30 |
|
31039049 | Current and emerging biologics for the treatment of hemophilia | Castaman G | 2019 May 09 |
|
30843692 | Redox-Controlled Site-Specific α2–6-Sialylation | Lu N | 2019 Mar 07 |
|
30820542 | Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates | Janas MM | 2019 Mar 01 |
|
30824758 | Glycosylation of Staphylococcus aureus cell wall teichoic acid is influenced by environmental conditions | Mistretta N | 2019 Mar 01 |
|
30591584 | Biosynthesis of O-N-acetylgalactosamine glycans in the human cell nucleus | Cejas RB | 2019 Mar 01 |
|
30500509 | Chondroitin sulfate isolated from the secretion of the venom-producing parotoid gland of Brazilian bufonid | da Silva HAM | 2019 Mar 01 |
|
31029427 | Identification of the O-GalNAcylation site(s) on FOXA1 catalyzed by ppGalNAc-T2 enzyme in vitro | Zhang S | 2019 Jun 18 |
|
31005367 | Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR) | Zhang Y | 2019 Jun 01 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025